A retrospective observational study of clinical presentation and management outcomes in patients with paroxysmal supraventricular tachycardia at a tertiary center in Bahrain
Frontiers in Cardiovascular Medicine · 14.04.2026 · 13
DOI: 10.3389/fcvm.2026.1739540 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 14.04.2026. Verfasst von Osama Zeidan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Royal College of Surgeons in Ireland, Medical University of Bahrain (RCSI-MUB), Busaiteen, Bahrain. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
This study aimed to evaluate the clinical characteristics, symptom presentation, and management outcomes of patients diagnosed with paroxysmal supraventricular tachycardia (PSVT) at King Hamad University Hospital (KHUH), a tertiary care center. It examined the influence of demographics, comorbidities, and sex on treatment responses to pharmacologic and non-pharmacologic interventions, including cardioversion.
Methods
A retrospective observational study was conducted on 427 adult patients with PSVT (ICD-10: I47.1, confirmed by chart review) between January 2018 and early 2024. Data were extracted from the KHUH HOPE electronic medical records system. Descriptive statistics summarized baseline characteristics; chi-square tests examined categorical associations. Kaplan–Meier analyses for the cardioversion subgroup ( n = 18) are presented as exploratory and descriptive only.
Results
Females comprised 56.9% of the cohort (mean age 52.8 ± 15.2 years). Palpitations were the most common symptom (94.4%). Of 219 patients who received adenosine, 177 (80.8%) achieved cardioversion with the first dose, 25 (11.4%) with the second, and 17 (7.8%) with the third. Vagal maneuvers showed reduced success in patients with structural heart disease and diabetes mellitus. Electrical cardioversion was required in 18 patients (4.2%). Pacemaker implantation was documented in 3 patients (0.7%) for co-existing conduction disease, not as a PSVT treatment. Comorbidities significantly influenced outcomes: hypertension was associated with favorable vagal maneuver response, while heart failure and ischemic heart disease correlated with poor response across all modalities.
Conclusion
PSVT generally responds well to first-line treatments. However, individualized strategies are warranted for patients with structural heart disease or significant comorbidities. Observed sex-based and age-related response differences are descriptive and require multivariable validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Royal College of Surgeons in Ireland, Medical University of Bahrain (RCSI-MUB), Busaiteen, Bahrain.
- College of Medicine, Sultan Qaboos University, Muscat, Oman.
- Cardiology Department, King Hamad University Hospital, Muharraq, Bahrain.
Zitieren
APA
Zeidan, O., Alohaly, A., Zayer, A., Jaragh, N., Alqayem, M., Ziedan, A., Fredericks, S., & Assar, W. (2026). A retrospective observational study of clinical presentation and management outcomes in patients with paroxysmal supraventricular tachycardia at a tertiary center in Bahrain. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1739540
Vancouver
Zeidan O, Alohaly A, Zayer A, Jaragh N, Alqayem M, Ziedan A, et al. A retrospective observational study of clinical presentation and management outcomes in patients with paroxysmal supraventricular tachycardia at a tertiary center in Bahrain. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1739540
BibTeX
@article{Zeidan2026,
author = {Zeidan, Osama and Alohaly, Aljazi and Zayer, Ali and Jaragh, Noor and Alqayem, Maryam and Ziedan, Ayat and Fredericks, Salim and Assar, Walid},
title = {A retrospective observational study of clinical presentation and management outcomes in patients with paroxysmal supraventricular tachycardia at a tertiary center in Bahrain},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1739540}
}
EUVIMED